Summit Therapeutics to Host Second Quarter 2026 Financial Results & Operational Progress Call on July 23, 2026 Life Science Investing
Greenwich LifeSciences Announces European Approval for Combining Both HLA Populations in FLAMINGO-01 Life Science Investing
BriaCell Opens First Canadian Site - Sunnybrook - for Pivotal Phase 3 Trial in Metastatic Breast Cancer Pharmaceutical Investing
Telo Genomics Provides Positive Interim Data from Ongoing Clinical Trial Advancing Genomic Instability-Based Relapse Risk Assessment Genetics Investing
Gain Therapeutics CEO Gene Mack Issues Letter to Shareholders and Provides Operational Update Life Science Investing
Compass Pathways Announces Publication of Post-Hoc Analysis Demonstrating Distinction of COMP360 Trial Monitoring & Support from Psychotherapy Psychedelics Investing
argenx to Report Half Year 2026 Financial Results and Second Quarter Business Update on July 23, 2026 Biotech Investing
Royalty Pharma to announce second quarter 2026 financial results on August 5, 2026 Life Science Investing
Acadia Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 4, 2026 Life Science Investing
KORU Medical Systems to Report Second Quarter 2026 Financial Results on August 5, 2026 Life Science Investing
